Nephron
Original Paper
Disturbances of Trace Element Concentrations in Plasma of Patients with Chronic Renal FailureTsukamoto Y. · Iwanami S. · Marumo F.Departments of Medicine and Radiology, Kitasato University School of Medicine, Kitasato
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Accepted: March 10, 1980
Published online: December 02, 2008
Issue release date: 1980
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 1660-8151 (Print)
eISSN: 2235-3186 (Online)
For additional information: https://www.karger.com/NEF
Abstract
Plasma concentrations of 6 essential trace elements were measured in undialyzed and hemodialyzed patients with chronic renal failure (CRF) and in healthy volunteers by tube-excited X-ray fluorescence analysis and atomic absorption analysis. The influences of hemodialysis on plasma concentrations of Al, Zn, Cu and Br were also studied. High plasma concentrations of Al and Cu and low concentrations of plasma Zn were found in nondialyzed patients with CRF. Plasma concentrations of Al and Cu increased and Zn and Br decreased in the hemodialyzed patients with CRF. An elevated concentration of plasma Al may be primarily caused by permeation from dialysate across the dialyzer membrane. The use of water produced by reverse osmosis will prevent the elevation of plasma Al concentration in patients with CRF.
© 1980 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Accepted: March 10, 1980
Published online: December 02, 2008
Issue release date: 1980
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 1660-8151 (Print)
eISSN: 2235-3186 (Online)
For additional information: https://www.karger.com/NEF
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission